PETALION THERAPEUTICS LIMITED
PETALION THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 15363420, incorporated on 20 December 2023. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 2 years. Registered office address: CB22 3FH Cambridge, the United Kingdom. Directors include THE CAMBRIDGE PARTNERSHIP LIMITED, MR SHYAM SASHIKANT MASRANI, and MR DAVID JOHN MCINTYRE, and 1 other. Associated with 20 related entities, including CASSINI BIO LIMITED, INTERACT BIO LTD, and VIMELA THERAPEUTICS LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
CAMBRIDGE PARTNERSHIP, DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS
BABRAHAM
CB22 3FH CAMBRIDGE
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 15363420 | 2026-06-01 | open_in_new |